Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has announcements
×
Carcinoma, Hepatocellular
×
Bevacizumab
×
Clear all
Filters
3
NCT03434379
2023-10-23
IMbrave150
Hoffmann-La Roche
Phase 3
Completed
558 enrolled
48 charts
2 FDA